International Perspectives on COVID-19 and Cancer
Researchers from around the globe share insights into cancer and the coronavirus.
Progress Against Cancer
Researchers from around the globe share insights into cancer and the coronavirus.
While the incidence of melanoma has been rising, the mortality rate has experienced a steep decline over the past few years. This is largely attributable to major advances in treatment during the past two decades, including the development of BRAF...
Testicular cancer forms when cancerous cells develop in one or both testicles. Almost all cases of the disease begin in the germ cells of the testicles, which are responsible for producing immature sperm. The two main types of testicular cancer are seminomas and nonseminomas, with nonseminomas typically being more aggressive.
A study shows that antibiotic use prior to starting immunotherapy for melanoma is associated with decreased survival and other cancer news of the week from the staff of Cancer Today.
Young adults with a history of cancer are more likely to try e-cigarettes than their peers, and more news of the week from Cancer Today.
The first allogeneic hematopoietic-cell transplant (HCT) – a complex procedure where a patient receives blood stem cells isolated from a healthy donor – was performed in 1957. Now, over 9,000 allogeneic hematopoietic-cell transplants are performed per year in the United States. This type of transplant is generally used to treat patients with bone marrow disorders, including certain types of leukemia, lymphoma, and multiple myeloma.
CAR-T cell therapy may help patients after a relapse of mantle cell lymphoma, and more news of the week from Cancer Today.
The world is facing a pandemic unlike any in living memory. For our cancer research community, the novel coronavirus epidemic evokes memories of the 2003 outbreak of Severe Acute Respiratory Syndrome (SARS), which had far-reaching effects including the rescheduling of American Association for Cancer Research (AACR) Annual Meeting. Yet the total reported caseload of SARS was approximately 8,000, with 774 deaths; only 29 cases were identified in the United States.
Cancer centers are making changes to care for some patients enrolled in trials.
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More